Alpha-2-HS-glycoprotein in multiple myeloma
Pavesi, F.; Merlini, G.; Epis, R.; Zorzoli, I.; Moratti, R.; Gorini, M.; Ascari, E.
Haematologica 67(6): 845-852
1982
ISSN/ISBN: 0390-6078 PMID: 6819190 Document Number: 188152
Document emailed within 1 workday
Related Documents
Carulli, G.; Petrini, M.; Marini, A.; Ambrogi, F.; Ucci, G.; Riccardi, A.; Luoni, R.; Grassi, B. 1990: P-glycoprotein expression in multiple myeloma Haematologica 75(3): 288-290Prowse, K.R.; Baumann, H. 1989: Multiple inflammation-inducible alpha 1-acid glycoprotein forms correlate with multiple genes in Mus caroli Progress in Clinical and Biological Research 300: 135-138
Gisslinger, H. 1997: Interferon alpha in the therapy of multiple myeloma Leukemia 11(Suppl 5): S52-S56
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Tarzia, R.; Meninno, V.; Lombardi, S.; Costanzo, A.; Canzano, G. 1984: Normal values of IgA, IgM, IgG, C3c, C4, alpha 1-acid glycoprotein in blood from the umbilical cord of healthy newborn infants using laser-nephelometry. III: C3c, C4, alpha 1-acid glycoprotein Bollettino della Societa Italiana di Biologia Sperimentale 60(2): 449-454
Cooper, M.R. 1991: A review of the clinical studies of alpha-interferon in the management of multiple myeloma Seminars in Oncology 18(5 Suppl 7: 18-29
Pisa, P.; Stenke, L.; Bernell, P.; Hansson, M.; Hast, R. 1990: Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients Anticancer Research 10(3): 817-820
Iakupova, E.V.; Grinchuk, O.V.; Kalimullina, D.Kh.; Bakirov, B.A.; Galimova, R.R.; Makarova, O.V.; Khusnutdinova, E.K.; Viktorova, T.V. 2003: Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma Molekuliarnaia Biologiia 37(3): 420-424
Udagawa, Y.; Armstrong, S.S.; Waites, G.T.; Bell, S.C.; Horne, C.H.; Thomson, A.W. 1985: Immunohistochemical localization of murine alpha 1-pregnancy-associated protein (alpha 1-PAP) in non-pregnant females: a comparative study with human pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) Clinical and Experimental Immunology 61(2): 397-405
Palumbo, A.P.; Garino, A.L.; Frieri, R.; Gallone, G.; Boccadoro, M.; Pileri, A. 1990: Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy Haematologica 75(6): 576-578
Case, D.C.; Sonneborn, H.L.; Paul, S.D.; Hiebel, J.; Boyd, M.A.; Shepp, M.A.; Dorsk, B.M.; Bonnem, E. 1986: Phase Ii study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase Cancer Treatment Reports 70(11): 1251-1254
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
Barillé, S.; Bataille, R.; Amiot, M. 2000: The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma European Cytokine Network 11(4): 546-551
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Oie, S.; Chiang, J. 1989: Alteration in the pharmacologic activity of alpha 1 adrenergic antagonists by alpha-1-acid glycoprotein Progress in Clinical and Biological Research 300: 235-238
Homolka, J.; Voslárová, Z.; Malbohan, I. 1987: Significance of alpha-1-antitrypsin and alpha-2-pregnancy-associated glycoprotein in the serum of patients with bronchial carcinoma Zeitschrift für Erkrankungen der Atmungsorgane 169(1): 38-43
De la Peña, J.; De las Heras, G.; Galo Peralta, F.; Casafont, F.; Pons Romero, F. 1991: Prospective study of the prognostic value of C reactive protein, alpha 1-antitrypsin and alpha 1-acid glycoprotein in acute pancreatitis Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 79(5): 337-340
Briese, V.; Willroth, P.O.; Brock, J.; Straube, W. 1984: Tumor markers (alpha 2-macroglobulin, secretory immunoglobulin A, pregnancy-associated alpha 2-glycoprotein) in the serum of patients with bronchial carcinoma Archiv für Geschwulstforschung 54(5): 391-398